Evidence for complex binding profiles and species differences at the translocator protein (TSPO) (18 kDa)

A M Scarf1, C Luus, E Da Pozzo

  • 1Discipline of Pharmacology, University of Sydney NSW 2006, Australia.

Current Molecular Medicine
|February 22, 2012
PubMed

Insights

Researchers developed new pyrrolobenzoxazepine compounds to study the translocator protein (TSPO), revealing species-specific binding and functional differences crucial for developing TSPO-targeted therapeutics.

Area of Science:

  • Pharmacology
  • Medicinal Chemistry
  • Neuroscience

Background:

  • The translocator protein (TSPO) is a key drug target for cancer and neurodegenerative diseases.
  • Limited understanding of TSPO binding sites impedes therapeutic ligand development.
  • Species-specific TSPO characteristics complicate drug discovery.

Purpose of the Study:

  • To synthesize and characterize pyrrolobenzoxazepine ligands for TSPO.
  • To investigate species differences in TSPO ligand binding and function.
  • To explore potential allosteric effects and cooperativity at TSPO binding sites.

Main Methods:

  • Synthesis of pyrrolobenzoxazepine compounds (1-10).
  • Competition binding assays using [3H]PK 11195 with rat and human TSPO.
  • Non-linear regression analysis to determine binding kinetics (Hill slope).
  • Functional assays: pregnenolone production, nitric oxide release, and cell proliferation.

Main Results:

  • All synthesized ligands bound to TSPO with nanomolar affinity.
  • Significant discrepancies in binding affinity were observed between rat and human TSPO.
  • Some ligands exhibited Hill slopes not equal to 1.0, suggesting allosteric modulation, but this was not conserved across species.
  • Functional effects in cellular assays did not correlate with binding affinities.

Conclusions:

  • Species differences in TSPO binding are critical and must be considered.
  • Potential allosteric effects and binding site cooperativity warrant further investigation.
  • Optimization of functional assays and consideration of species variability are essential for developing effective TSPO-based therapeutics.

Related Concept Videos

Protein Translocation Machinery on the ER Membrane01:28

Protein Translocation Machinery on the ER Membrane

The translocon complex situated on the ER membrane is the main gateway for the protein secretory pathway. It facilitates the transport of nascent peptides into the ER lumen and their insertion into the ER membrane.
Sec61 protein conducting channel
In eukaryotes, the translocon complex comprises a core heterotrimeric translocator channel called the Sec61 complex. This channel includes three transmembrane proteins, Sec61α, Sec61β, and Sec61γ, and is the largest subunit of the translocon complex.
Cotranslational Protein Translocation01:20

Cotranslational Protein Translocation

Translocation of proteins across membranes is an ancient process that occurs even in bacteria and archaebacteria. In fact, the components of the translocation machinery are still conserved between prokaryotes and eukaryotes.
Sec61 channel partners for cotranslational translocation
During cotranslational translocation, the Sec61 channel partners with the signal recognition particle (SRP), the signal recognition particle receptor (SR), and the ribosomes to transport the nascent polypeptide chain...
The Significance of Membrane Transport01:44

The Significance of Membrane Transport

The transport of solutes across the cell membrane is essential for metabolic processes, like maintaining cell size and volume, generating the action potential, exchanging nutrients and gases, etc. Membrane transport can be either passive or active. It can be simple diffusion, facilitated, or mediated transport aided by transport proteins such as transporters and channels.
Transporters facilitate either an active or passive movement of solutes. They can allow a single-molecule transport down its...
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...